Skip to main content

Advertisement

Log in

The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

The Z0011 trial questioned the role of axillary ultrasound (AxUS) in preoperative staging of breast cancer in patients with ≤2 positive sentinel lymph nodes (SLN). The purpose of this study was to correlate the number of abnormal nodes on AxUS with final nodal burden and determine the utility of AxUS with sampling (AxUS + S) in preoperative staging.

Methods

Six hundred and seventy-nine patients underwent pre-operative AxUS. Suspicious nodes were sampled. Negative axillae proceeded to SLN biopsy. The number of abnormal nodes identified on ultrasound and final histology as well as sensitivity and specificity for AxUS + S were calculated. Subgroup analysis was performed on Z0011 eligible patients.

Results

Two hundred and ninety-six patients had positive axillary nodes on final histology with 169 detected by AxUS + S (sensitivity 86.2 %, specificity 100 %, PPV 100 %, NPV 71.9 %). Patients with nodal metastases identified by AxUS had a mean burden of 7.3 nodes on histology (1 node on AxUS = 5.2 nodes on histology, 2 nodes on AxUS = 7.5 nodes, >2 nodes = 10.1 nodes). Patients diagnosed on SLNB had a mean burden of 2.2 nodes.

Conclusion

A single nodal metastasis detected on AxUS + S correlated with a mean of 5.2 nodes on final histology highlighting that AxUS remains essential in guiding appropriate management of the axilla in breast cancer.

Key Points

Axillary ultrasound +/- sampling is an essential technique in preoperative axillary staging.

Axillary ultrasound findings correlate with final histological axillary node disease burden.

Axillary ultrasound can help triage patients who require axillary lymph node dissection.

The role of axillary ultrasound in breast cancer staging continues to evolve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

SLNB:

Sentinel lymph node biopsy

PPV:

Positive predictive value

NPV:

Negative predictive value

ALND:

axillary lymph node dissection

AxUS:

axillary ultrasound

FNAC:

Fine needle aspiration cytology

CB:

Core biopsy

Ax-US + S:

axillary ultrasound + sampling (FNAC or CB)

References

  1. Samphao S, Eremin JM, El-Sheemy M, Eremin O (2008) Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol 15:1282–96

    Article  PubMed  Google Scholar 

  2. Abrams JS (2001) Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 8:298–304

    Article  CAS  PubMed  Google Scholar 

  3. Mills P, Sever A, Weeks J et al (2010) Axillary ultrasound assessment in primary breast cancer: an audit of 653 cases. Breast J 16:460–463

    Article  PubMed  Google Scholar 

  4. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599e609

    Article  Google Scholar 

  5. Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881e8

    Article  Google Scholar 

  6. Lucci A, McCall LM, Beitsch PD, American College of Surgeons Oncology Group et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol 25:3657–3663

    Article  PubMed  Google Scholar 

  7. Houssami N, Ciatto S, Turner RM, Cody HS III, Macaskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254:243e51

    Article  Google Scholar 

  8. Glynn RW, Williams L, Dixon JM (2010) A further survey of surgical management of the axilla in UK breast cancer patients. Ann R Coll Surg Eng 92:506–11

    Article  Google Scholar 

  9. http://www.nice.org.uk/nicemedia/pdf/CG80NICEGuideline.pdf. National Institute for Clinical excellence clinical guideline 80: Early and locally advanced breast cancer, diagnosis and treatment

  10. Rattay T, Muttalib M, Khalifa E, Duncan A, Parker SJ (2012) Clinical utility of routine pre-operative axillary ultrasound and fine needle aspiration cytology in patient selection for sentinel lymph node biopsy. Breast 21:210–4

    Article  CAS  PubMed  Google Scholar 

  11. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569e75

    Google Scholar 

  12. Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–32

    PubMed  Google Scholar 

  13. Solon JG, Power C, Al-Azawi D, Duke D, Hill AD (2012) Ultrasound-guided core biopsy: an effective method of detecting axillary nodal metastases. J Am Coll Surg 214:12–7

    Article  PubMed  Google Scholar 

  14. Carroll PA, O'Mahony D, McDermott R et al (2011) Perioperative diagnosis of the positive axilla in breast cancer: a safe, time efficient algorithm. Eur J Surg Oncol 37:205–10

    Article  CAS  PubMed  Google Scholar 

  15. Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer–a multicenter validation study. N Engl JMed 339:941–946

    Article  CAS  Google Scholar 

  16. Britton P, Moyle P, Benson JR et al (2010) Ultrasound of the axilla: where to look for the sentinel lymph node. Clin Radiol 65:373–376

    Article  CAS  PubMed  Google Scholar 

  17. National Institutes of Health (1991) NIH consensus conference on the treatment of early stage breast cancer. JAMA 265:391–395

    Article  Google Scholar 

  18. Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–20

    Article  PubMed  Google Scholar 

  19. Ivens D, Hoe AL, Podd TJ et al (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136–138

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Duff M, Hill AD, McGreal G et al (2001) Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg 88:114–117

    Article  CAS  PubMed  Google Scholar 

  21. Genta F, Zanon E, Camanni M et al (2007) Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 31:1155–63

    Article  PubMed  Google Scholar 

  22. Turaga KK, Chau A, Eatrides JM, Kiluk K et al (2011) Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist 16:942–8

    Article  PubMed Central  PubMed  Google Scholar 

  23. Cools-Lartigue J, Meterissian S (2012) Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review. World J Surg 36:46–54, Review

    Article  PubMed  Google Scholar 

  24. Gnant M, Harbeck N, Thomssen C (2011) St Gallen 2011: summary of the consensus discussion. Breast Care 2011:136–41

    Article  Google Scholar 

  25. Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA (2013) Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR 200:696–702

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The scientific guarantor of this publication is Dr Sylvia O’Keeffe. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was not required because of the retrospective nature of this study. This is a retrospective observational study performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. P. J. Farrell.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farrell, T.P.J., Adams, N.C., Stenson, M. et al. The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?. Eur Radiol 25, 2682–2687 (2015). https://doi.org/10.1007/s00330-015-3683-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3683-6

Keywords

Navigation